MedTrace Logo

Indomethacin for Tocolysis of Preterm Labor

NCT01869361 · Status: WITHDRAWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL

Last updated 2021-12-07

No results posted yet for this study

Summary

Indomethacin for tocolysis for 48 hours vs placebo

Conditions

  • Preterm Labor

Interventions

DRUG

Indomethacin

Study drug

DRUG

Placebo

Control drug

Sponsors & Collaborators

  • MetroHealth Medical Center

    lead OTHER

Principal Investigators

  • Kelly S Gibson, MD · MetroHealth Medical Center

  • Brian Mercer, MD · MetroHealth Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2021-11-23
Completion
2021-11-23
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01869361 on ClinicalTrials.gov